Catalyst Ryukyu

Catalyst Inc. is a biotechnology company based in Okinawa, Japan, that specializes in the expression and purification of challenging membrane proteins for drug discovery. The company utilizes its proprietary C-REX (Catalyst-Rapid EXpression) platform to produce high-quality, functional proteins such as G-protein coupled receptors (GPCRs), ion channels, and transporters. These proteins are essential for structure-based drug design and the development of therapeutic antibodies. Catalyst operates as both a service provider for pharmaceutical partners and an internal drug discovery entity. By stabilizing proteins that are traditionally difficult to handle, the company enables the discovery of new treatments for various diseases, including cancer and neurological disorders.